Specialized Consumer Services

WW INTERNATIONAL INC

Bruce Galloway Holds 8.42% of WW International and Plans to Communicate

WW International reports Q1 2026 net loss of $52 million

WW International completes restructuring and focuses on GLP-1 products

WW International Plans to Release Q1 2026 Earnings Report

WW International plans to repay up to $40 million in term loans ahead of schedule

WW International Reports Q3 2025 Earnings with a Loss of $1.04 per Share

WW International Reports Q4 Revenue Decline But Clinical Subscriptions Revenue Growth

WeightWatchers to Report Q4 Earnings

WW International Inc. released FY2025 Q1 earnings on May 6 (EST), actual revenue USD 186.57 M (forecast USD 180.26 M), actual EPS USD -0.91

WW International Inc. released FY2024 Q1 earnings on May 6 After-Market EST, actual revenue USD 206.55 M (forecast USD 199.39 M), actual EPS USD -4.3922

WW International Inc. released FY2024 Q2 earnings on May 6 Pre-Market EST, actual revenue USD 202.07 M (forecast USD 208.87 M), actual EPS USD 0.29

WW International Inc. released FY2024 9 Months Earnings on May 6 Pre-Market EST, actual revenue USD 601.51 M, actual EPS USD -4.6822

WW International Inc. released FY2024 Semi-Annual Earnings on May 6 Pre-Market EST, actual revenue USD 408.62 M, actual EPS USD -4.0913

WW International Inc. released FY2024 Q3 earnings on May 6 Pre-Market EST, actual revenue USD 192.89 M (forecast USD 193.44 M), actual EPS USD -0.58

WW International Inc. released FY2024 annual earnings on February 28 After-Market EST, actual revenue USD 785.92 M (forecast USD 776.42 M), actual EPS USD -4.3441

WW International Inc. released FY2023 earnings on February 28 After-Market EST, actual revenue USD 889.55 M (forecast USD 890.36 M), actual EPS USD -1.4639

WW International Inc. released FY2024 Q4 earnings on February 28 After-Market EST, actual revenue USD 184.41 M (forecast USD 173.23 M), actual EPS USD 0.3144

WW International Inc. released FY2022 earnings on February 28 After-Market EST, actual revenue USD 1.04 B (forecast USD 1.042 B), actual EPS USD -3.6527

WW International Inc. released FY2023 Q4 earnings on February 28 After-Market EST, actual revenue USD 205.96 M (forecast USD 206.91 M), actual EPS USD -1.1138

WW International Inc. released FY2023 9 Months Earnings on November 6 After-Market EST, with actual revenue of USD 683.6 M and EPS of USD -0.4911

InMed Pharmaceuticals

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

Amesite

CN Energy

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

NextNRG

Meiwu Tech

Generation Income Properties

MetaVia

OceanPal

WGHTQ

Galloway Capital Partners has acquired an 8.42% stake in WW International, asserting that the company is significantly undervalued despite its strong brand and growth in the wellness sector. Following a debt reduction from $1.4 billion to $460 million, WW's market cap has dropped below $100 million. Galloway highlights WW's 50% annual growth in its clinical business and valuable member data. Currently trading at 3.7x EBITDA, Galloway believes WW's true value is much higher and aims to work with the board to enhance shareholder value.

Fidelity

Galloway Capital Partners Announces Investment in WW International and Believes Shares Are Worth Multiples of Current Price

Bruce Galloway, through Galloway Capital Partners, LLC and Galloway Capital, LP, has disclosed an 8.42% stake in WW International, Inc. as of May 13, 2026. He intends to engage with the company's leadership on various aspects including performance and governance. Galloway may buy more shares or propose formal actions as he reviews the company's operations and strategy. He is known for targeting small and mid-cap companies to unlock value through operational changes.

TradingView

Bruce Galloway Takes Activist Stake at WW International with 8.42% Stake

WW International shares are trading lower after the company reported mixed Q1 financial results and reaffirmed its FY26 sales guidance with its midpoint below estimates.

benzinga_article

Yesterday's closing price for Weight Watchers was $10.15, down 3.61% from the previous trading day. The MACD indicator shows a death cross signal, indicating a bearish short-term technical outlook, and the unstable market sentiment has increased risk warnings. Trading volume has increased compared to previous periods, but the nature of the funds leans more towards short-term selling. On the news front, despite the stable potential demand in the weight loss and health management market, WTW faces issues of brand aging and unclear product diversification strategies. Industry competition comes not only from traditional weight loss services but also from the ongoing penetration of technology and internet-listed companies. The tense situation in the US-Iran region and uncertainty in major economic activities have led to increased demand for safe-haven assets, coupled with unclear signals of easing from the Federal Reserve's meeting communications, putting pressure on the consumer goods sector. Technical indicators show that the stock price has broken below the horizontal price range formed over the past month; if it falls below the $10 mark again, it may indicate further declines. Recently, the pressure from forced selling has intensified, and the willingness to support buying is weak, creating a negative cycle. The short-term trend is biased towards bearishness, and the impact of diversification and transformation needs to be continuously observed. Investors should pay attention to controlling their positions to manage risk and avoid blindly increasing their holdings. This article is for technical analysis and market information reference only and does not constitute any investment advice

Technical Forecast

Willis Towers Watson

Pre-market trend | Weight Watchers (WTW) on May 1st shows intensified downward momentum, with support line under severe pressure?

Weight Watchers Expands Med+ With Access to New Ozempic® pill (semaglutide) | WW Stock News

StockTitan

Weight Watchers Expands Med+ With Access to New Ozempic® pill (semaglutide) | WW Stock News

WW International (NASDAQ:WW) is set to release its Q1 2026 earnings on May 7, with analysts predicting a loss of $0.94 per share and revenue of $149.80 million. The company previously reported a loss of $0.58 per share for Q1 2025, exceeding expectations. WW's stock opened at $10.13, with a market cap of $101.27 million. Institutional investors hold 86.18% of the stock, and analysts currently rate it as "Reduce". WW International focuses on wellness and weight management, offering subscription programs and digital tools.

Market Beat

SPDR S&P Health

iShares US Healthcare Providers

Palantir Tech

Woodward

Ameriprise Financial

WW International (WW) to Release Quarterly Earnings on Thursday

WW (WW International, Inc.) is set to announce its Q1'26 results on May 07, after the market closes. The earnings are expected to be disclosed at 9:30 AM ET (1:30 PM UTC).For Q1'26, revenue estimate is 158.53 million USD with EPS (earnings per share) anticipated at (2.45) USD. Learn more details at .Revenue & EPS values are provided in USDQ1'25Q2'25Q3'25Q4'25Q1'26Revenue Reported186.57 M189.00 M172.09 M162.81 M—Revenue Estimate—178.05 M161.38 M149.80 M158.53 MRevenue Surprise+6.15%+6.64%+8.69%EPS Reported(2.11) 14.43(5.76)(0.58) EPS Estimate(0.03) 0.51(0.85)(2.45) EPS Surprise+57820.00%-1229.41%+31.50%DisclaimerSelect reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc.

Factset Research

WW Q1'26 Earnings: revenue estimate is 158.53M USD

WW INTERNATIONAL INC(WGHTQ.US)

Galloway Capital Partners Announces Investment in WW International and Believes Shares Are Worth Multiples of Current Price

Bruce Galloway Takes Activist Stake at WW International with 8.42% Stake

WW International shares are trading lower after the company reported mixed Q1 financial results and reaffirmed its FY26 sales guidance with its midpoint below estimates.

Pre-market trend | Weight Watchers (WTW) on May 1st shows intensified downward momentum, with support line under severe pressure?

Weight Watchers Expands Med+ With Access to New Ozempic® pill (semaglutide) | WW Stock News

WW International (WW) to Release Quarterly Earnings on Thursday

WW Q1'26 Earnings: revenue estimate is 158.53M USD